Reoperation for secondary uremic hyperparathyroidism: Are technical difficulties influenced by initial surgical procedure?

医学 甲状旁腺切除术 甲状旁腺功能亢进 外科 继发性甲状旁腺功能亢进 甲状旁腺激素 内科学
作者
Pierre Cattan,Bruno Halimi,Karen Aïdan,Claire Billotey,Carmen Tamas,Tilman B. Drüeke,E. Sarfati
出处
期刊:Surgery [Elsevier]
卷期号:127 (5): 562-565 被引量:25
标识
DOI:10.1067/msy.2000.105865
摘要

Background. Parathyroid surgery in patients with uremia and secondary hyperparathyroidism is performed either by subtotal parathyroidectomy or total parathyroidectomy with immediate reimplantation. The aim of this study was to compare the results of reoperation for persistent or recurrent hyperparathyroidism after parathyroidectomy according to which initial operative procedure was used. Patients and methods. Eighty-nine patients had reoperation for persistent (28 patients) or recurrent (61 patients) hyperparathyroidism after 53 subtotal parathyroidectomies and 36 total parathyroidectomies with immediate reimplantation. Results of the reoperation were assessed in terms of success rate, morbidity, and operative findings. Results. The success rate of reoperation in patients with persistent hyperparathyroidism was 89% and was independent of the initial type of surgery. Success rates of reoperation for recurrent hyperparathyroidism after initial subtotal parathyroidectomy and total parathyroidectomy with immediate reimplantation were 87% and 70%, respectively (P =.02). Hypertrophy of the parathyroid remnant was the main cause of recurrence after subtotal parathyroidectomy. After total parathyroidectomy with immediate reimplantation, recurrence was located in the graft in half the patients, while hyperplastic tissue was found in the neck or the mediastinum in the other half. Conclusions. Subtotal parathyroidectomy provides the best conditions for successful reoperation in case of recurrent hyperparathyroidism and should become the surgical treatment of choice for secondary hyperparathyroidism. (Surgery 2000;127:562–5.)

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
quzhenzxxx完成签到 ,获得积分10
刚刚
科研通AI6.1应助小美采纳,获得10
刚刚
天天向上完成签到 ,获得积分10
刚刚
1秒前
510关闭了510文献求助
2秒前
烂漫依琴发布了新的文献求助10
3秒前
明亮的犀牛完成签到,获得积分10
3秒前
小颖完成签到 ,获得积分10
3秒前
4秒前
zyh完成签到 ,获得积分10
4秒前
5秒前
5秒前
今后应助动听身影采纳,获得10
6秒前
芋头儿完成签到,获得积分10
7秒前
小小完成签到 ,获得积分10
7秒前
7秒前
inches完成签到 ,获得积分10
7秒前
青蛙呱呱发布了新的文献求助10
8秒前
wcwpl发布了新的文献求助10
8秒前
9秒前
义气雨南发布了新的文献求助10
10秒前
刮风这天完成签到,获得积分10
10秒前
科研通AI2S应助张行采纳,获得10
10秒前
无人深空完成签到,获得积分10
10秒前
研友_Lk9zzZ完成签到,获得积分10
11秒前
11秒前
科研通AI6.3应助开朗嵩采纳,获得10
11秒前
12秒前
halo完成签到,获得积分20
12秒前
12秒前
12秒前
13秒前
14秒前
15秒前
15秒前
阿申爱乐应助Daniel采纳,获得30
15秒前
研友_Lk9zzZ发布了新的文献求助10
16秒前
zxx发布了新的文献求助10
16秒前
16秒前
17秒前
高分求助中
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Handbook of pharmaceutical excipients, Ninth edition 1500
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6009604
求助须知:如何正确求助?哪些是违规求助? 7550257
关于积分的说明 16131137
捐赠科研通 5156136
什么是DOI,文献DOI怎么找? 2761814
邀请新用户注册赠送积分活动 1740125
关于科研通互助平台的介绍 1633172